Charts Thiogenesis Therapeutics, Corp. OTC Markets

Stocks

Market Closed - OTC Markets 14:30:19 07/08/2026 BST			5-day change	1st Jan Change
0.4200 ^USD	+7.69%		0.00%	-28.01%

08-06	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-13	Thiogenesis Therapeutics Receives Fda Rare Pediatric Disease Designation for Tti-0102 for the Treatment of Leigh Syndrome	CI

Stock exchange

OTC Markets TTIP.F 0.4200 $ +7.69% 42 $

Markets		Price	Change	Volumes
Toronto S.E.	TTI	0.5000CAD	-9.09%	103K $
OTC Markets	TTIP.F	0.4200USD	+7.69%	42 $
Deutsche Boerse AG	Q8M	0.3160EUR	0.00%	0 €

ProRealTime Chart